Pharma will pay more for Medicare and provide more opioid crisis funding as Congress passes new two year budget deal, Bioverativ exec fortunes from Sanofi buyout, Teva’s pain may be Mylan’s gain, and more
Embed from Getty ImagesFor banking news and anonymous forums, be sure to check out cafebanking.com
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,